癌症免疫治疗中的腺素:在新的飞机上起飞
Chenyue Zhang1, Kai Wang2, Haiyong Wang3
1Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, China.
Biochimica et biophysica acta. Reviews on cancer
|November 1, 2023
概括
向腺路径,特别是CD39,CD73和A2A受体,可以增强癌症免疫疗法. 阻止这种途径在克服瘤微环境中的免疫抑制方面显示出有希望,以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤免疫疗法提供了持久的反应,但面临着较低的反应率,需要新的治疗策略.
- 腺路径,特别是细胞外腺,在抑制瘤微环境中的抗瘤免疫反应方面发挥着至关重要的作用.
- 氨酸作用于各种免疫细胞 (MDSC,Tregs,NK细胞,T细胞,DCs,巨细胞) 上的A2A类受体,以促进瘤免疫逃逸.
研究的目的:
- 审查CD39-CD73-A2AR途径在塑造瘤微环境中的作用.
- 讨论治疗色协同路径的向作为癌症治疗策略.
- 突出结合腺通路阻塞与其他癌症疗法的潜力.
主要方法:
- 对癌症中腺路径的临床前研究的审查.
- 对正在进行和早期针对CD39,CD73和A2A受体的临床试验的分析.
- 检查抑制腺路径对免疫细胞和瘤反应的影响.
主要成果:
- 临床前数据支持腺路径作为一种新的免疫疗法检查点.
- 早期临床试验显示CD39,CD73和A2A受体抑制剂在各种癌症 (乳腺癌,前列腺癌,非小细胞癌) 中具有抗瘤功效.
- 腺素通路阻塞表明,当与其他癌症治疗相结合时,有可能提高反应.
结论:
- 向CD39-CD73-A2AR通路是克服瘤微环境中的免疫抑制的一个有希望的策略.
- 涉及腺通路阻塞的组合疗法可能会改善癌症患者的临床结果.
- 进一步的临床试验至关重要,以充分实现瘤学中腺能途径向的潜力.
相关概念视频
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
Cancer Vaccines
380
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
380
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


